Biosynthesis of niacin from 3-hydroxyanthranilic acid (3-OHAA) in normal and streptozotocin diabetic rats was studied in vivo and in vitro. Streptozotocin (SZ) diabetic rats were found to excrete lesser quantities of 3-OHAA, quinolinic acid, niacin and N1-methyl nicotinamide (NMN) in their urines following 3-OHAA administration than corresponding normal rats. In vitro studies indicated that SZ diabetic livers form less quinolinic acid from 3-OHAA than normal livers. It appears that this may be due to elevated picolinic carboxylase activity in the livers of SZ diabetic rats.
Biosynthesis of niacin from tryptophan has been found to be affected in diabetic conditions, clinical (1, 2) as well as experimental (3, 4) . The present authors recently reported that SZ-diabetic rats also exhibit faulty conversion of tryptophan into niacin; such rats were observed to excrete lesser quantities of niacin and NMN in their urines following tryptophan administration than the corresponding nondiabetic normal rats (5) . SZ-diabetic rats have also been found to excrete comparatively larger quantities of kynurenine, 3-hydroxykynurenine and xanthurenic acid on tryptophan load as compared to the normal nondiabetic rats (6) . In view of these observations, it was thought worthwhile to study the effects of suitable intermediates of tryptophan-niacin metabolism on niacin bio synthesis, both in vivo and in vitro with a view to pinpoint the site of the metabolic lesion. Of the three important intermediates-kynurenine, 3-OHAA and 3 -hydroxykynurenine, only 3-OHAA has been found to be useful in both, in vivo and in vitro, studies. Kynurenine and 3-hydroxykynurenine do not give rise to appreciable quantities of niacin in vitro under the conditions described in this communication. Only 3-OHAA under in vitro conditions is effectively converted into quinolinic acid, which can be converted into niacin by treatment with glacial acetic acid (7) . In vivo conversion of 3-OHAA into niacin has been reported by TENCONI (4) . The present article describes the experiments conducted to study the conver sion of 3-OHAA into niacin in SZ-diabetic rats, both in vivo and in vitro.
EXPERIMENTAL
Male albino rats of Wistar strain weighing 200-230g were employed in the present investigations. Some of the rats were made diabetic by intravenous in jection of SZ at the level of 65 mg per kg body weight, dissolved in citrate buffer of pH 4.5. SZ was kindly supplied by Upjohn International, Inc., Kalamazoo, Michigan, U. S. A. The control rats were injected with the buffer alone. Some of the diabetic and control rats were kept on a niacin-deficient diet for 3 weeks and the remaining animals were kept on a stock laboratory diet. The composi tions of both the diets are given in Table 1 . Rats kept on a niacin-deficient diet were transferred to metabolic cages after 3 weeks and their urines collected and analysed. Then they were injected with 3-OHAA and the urine samples for the following 24hr were collected under toluene and analysed. The results obtained are presented in Table 2 .
3-OHAA was determined by the method of Brown and Price as described by TENCONI (4), quinolinic acid and niacin in urine were determined by the cyanogen bromide method described by TENCONI (4) and NMN estimation was carried out by the procedure described by HUFF and PERLZWEIG (8) .
Rats kept on stock laboratory diet were used for in vitro studies after 15 Quinolinic acid is expressed here as niacin after its conversion into niacin by the acid treatment. Table 2 indicates the urinary excretion of tryptophan-niacin metabolites in normal and SZ-diabetic rats kept on a niacin-deficient diet before and after ad ministration of 3-OHAA. Excretion of all the metabolites examined increased after 3-OHAA injection, but the increase in the excretion of quinolinic acid, niacin and NMN was significantly less in diabetic rats as compared to the normal controls. Diabetic rats also tended to exhibit lower urinary values of 3-OHAA.
RESULTS AND DISCUSSION
Results obtained with in vitro studies are presented in Table 3 . Homogenates containing 3-OHAA and treated with glacial acetic acid exhibited higher values of niacin as compared to the flasks without the addition of 3-OHAA and treated with glacial acetic acid. The increase in niacin values was, however, significantly less in the livers of SZ-diabetic rats. P values in Table 3 indicate the level of signifi cance in the difference in the increase in value of the metabolite in the diabetic rats after the treatment in vivo and in vitro as compared to the normal rats. The results thus indicate that the diabetic livers convert 3-OHAA into quinolinic acid significantly less than the normal livers.
It has been reported that in alloxan-diabetic rats there is a marked elevation in the activity of the hepatic picolinic carboxylase (10) . This enzyme is involved in the conversion of the oxidation product of 3-OHAA into picolinic acid. The increased activity of this enzyme will divert the niacin biosynthetic pathway to wards picolinic acid, thereby causing reduced formation of quinolinic acid and consequently of niacin. IKEDA et al. (11) have noted a decrease in NAD synthesis in alloxan-diabetic rats in vivo and in vitro, which they contribute to the elevated hepatic picolinic carboxylase activity. Pancreatectomized rats have also been found to exhibit faulty niacin biosynthesis from 3-OHAA in vivo (4) and in vitro (12) .
It appears that the results reported in this paper may be due to a similar meta bolic lesion in SZ-diabetic rats. Experiments conducted in this laboratory have indicated about fourfold increased activity of picolinic carboxylase in SZ-diabetic livers as compared to that of normal control livers (unpublished data), as a result of which the metabolic pathway from 3-OHAA to niacin is diverted largely towards picolinic acid. This may thus be a contributing factor in the reduced conversion of 3-OHAA into quinolinic acid, and ultimately niacin, in the SZ-diabetic rats.
